Halozyme Therapeutics | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amarin USD 42.3M 25.19M 2024-09
Amgen USD 9.09B 583M 2024-12
Baxter International USD 2.75B 54M 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
DBV Technologies USD 560K 512K 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Indivior 298M 9M 2024-12
Intra Cellular Therapies USD 199.22M 23.85M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
MannKind USD 76.78M 6.7M 2024-12
Pfizer USD 17.76B 61M 2024-12
United Therapeutics USD 735.9M 13M 2024-12



Halozyme Therapeutics Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.